TESTIS CANCER RECURRENT

TESTIS CANCER RECURRENT was reported 10 times

TESTIS CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 5-alpha Reductase Inhibitor [EPC] 2 0.0000
1 Integrin Receptor Antagonist [EPC] 1 0.0000
2 Antirheumatic Agent [EPC] 1 0.0000
3 Retinoid [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 1 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
6 Atypical Antipsychotic [EPC] 1 0.0000
7 Tumor Necrosis Factor Blocker [EPC] 2 0.0000